• Chemotherapy Order Entry Regimens and Patient
  Safety Principles
• White Blood Cell Growth Factors Guideline Orders
  and Flow Sheet
• Drug, Dose & Schedule Recommendations for
  Antiemetics Regimens
• Breast Cancer Treatment Plan and Treatment Summary

“IMPAC has been diligently working to proactively adopt ASCO recommendations, as well as demonstrate core EHR elements,” says Suzanne Marshall, Medical Oncology Business Marketing Manager for IMPAC. “We are pleased to have the opportunity to demonstrate one-on-one how MOSAIQ can provide comprehensive clinical support for both medical and radiation oncology.”

“Participating in the EHR Lab is a terrific way to introduce meeting attendees to the new, intelligent design of MOSAIQ Medical Oncology,” says James P. Hoey, President and CEO of IMPAC Medical Systems. “Offering clinicians an oncology charting solution that makes planning, ordering and monitoring chemotherapy treatments easy, no other oncology EHR has the ability to deliver a comprehensive solution customized to fits their specific needs.”

The EHR Lab, located in McCormick Place, in the East Building, Room E253, will be open during the following hours:

• Friday, May 30, 2008, 1 p.m. - 6 p.m.
• Saturday, May 31, 2008, 9 a.m. - 5 p.m.
• Sunday, June 1, 2008, 9 a.m. - 5 p.m.

For additional information regarding ASCOs EHR Lab, visit: www.asco.org/ehr. For full details and a demonstration of IMPAC’s oncology EHR, MOSAIQ, visit IMPAC booth #18063.

About the American Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians of all oncology subspecialties who care for people with cancer. ASCOs nearly 25,000 members from the United States and abroad set the standard for patient care and lead the efforts to discover more effective cancer treatments, increase funding for clinical and translational research, and, ultimately, improve cancer care for the estimated 10 million people diagnosed with cancer worldwide each year.

ASCO publishes the Journal of Clinical Oncology (JCO), the preeminent, peer-reviewed, medical journal on clinical cancer research, and produces People Living with Cancer (www.plwc.org), a comprehensive consumer website providing oncologist-vetted cancer information to help patients and families make informed health-care decisions.

About IMPAC Medical Systems, Inc.
IMPAC Medical Systems provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care.

IMPAC is part of the Elekta Group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders.

With more than 2,500 employees globally, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information can be found at www.impac.com and www.elekta.com.